Cargando…
Oral Thromboprophylaxis Following Total Hip or Knee Replacement: Review and Multicentre Experience with Dabigatran Etexilate
The risk of venous thromboembolism (VTE) in patients undergoing total knee or hip replacement surgery is high. As a result, thromboprophylaxis is highly recommended. While current thromboprophylactic agents, such as low molecular weight heparins (LMWH) and vitamin K antagonists, are safe and effecti...
Autores principales: | Kendoff, D, Perka, C, Fritsche, H.M, Gehrke, T, Hube, R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263520/ https://www.ncbi.nlm.nih.gov/pubmed/22276081 http://dx.doi.org/10.2174/1874325001105010395 |
Ejemplares similares
-
Dabigatran etexilate for thromboprophylaxis in over 5000 hip or knee replacement patients in a real-world clinical setting
por: Rosencher, Nadia, et al.
Publicado: (2016) -
The Discovery of Dabigatran Etexilate
por: van Ryn, Joanne, et al.
Publicado: (2013) -
Dabigatran etexilate tetrahydrate
por: Liu, Hong-Qiang, et al.
Publicado: (2012) -
New options with dabigatran etexilate in anticoagulant therapy
por: Maegdefessel, Lars, et al.
Publicado: (2010) -
Dabigatran-etexilate: Lack of efficacy: case report
Publicado: (2021)